Madam Chair, the member understands that the use of rapid tests is obviously an asset to jurisdictions but it does require careful guidance and utilization to make sure that the tests are used in a way that can actually add to the benefit of containing COVID-19. That is why not only have we been procuring rapid tests and rapidly, no pun intended, deploying them across the country to provinces and territories, but we also worked with provinces and territories to release, through the special advisory committee, updated screening and testing guidance so that we could actually understand how best to use which test for which purpose and in which setting. Again, all with the effort to contain COVID-19.
On the distribution side, we have distributed over 4.6 million rapid tests to provinces and territories to date. In Ontario it is over two million. In Quebec it is over 1.2 million, and in B.C. it is 354,000. Some provinces and territories are using these in novel ways. For example, I understand in Nova Scotia they have been deployed for use in bars and restaurants in certain pilot project settings, to understand the transmission in those settings. Other provinces are beginning to deploy them in long-term care facilities where there is a need for very quick turnaround and understanding for people who are symptomatic of whether or not they are COVID-positive, but some provinces and territories have not deployed their tests yet. We are working with—